Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Comments and Responses

Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120–127

  1. Ninon Foussard,
  2. Audrey Cougnard-Gregoire,
  3. Kalina Rajaobelina,
  4. Cécile Delcourt,
  5. Catherine Helmer,
  6. Thierry Lamireau,
  7. Laurence Blanco,
  8. Laure Alexandre,
  9. Kamel Mohammedi and
  10. Vincent Rigalleau⇑
  1. Endocrinology, Diabetology, and Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
  1. Corresponding author: Vincent Rigalleau, vincent.rigalleau{at}chu-bordeaux.fr.
Diabetes Care 2018 Jun; 41(6): e101-e101. https://doi.org/10.2337/dc18-0069
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

We were interested by the article from Kelly et al. (1), who reported that markers of subclinical renal damage predicted later preeclampsia (PE) in pregnant women with type 1 diabetes mellitus (T1DM). Although the best predictor was neutrophil gelatinase-associated lipocalin, our interest focused on the higher estimated glomerular filtration rates (determined by the Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] equation) before preeclampsia. Hyperfiltration is considered an important early step of diabetic nephropathy, but it should be noted that glomerular filtration rates are not properly predicted in pregnancy, by any formula, including the CKD-EPI (2).

Much more common than T1DM, gestational diabetes mellitus (GDM) also predisposes to pregnancy-induced hypertension and PE, and subclinical renal abnormalities such as elevated albumin excretion rates have been reported in such cases; however we do not know whether serum creatinine may be abnormal before PE in GDM. It is also unknown whether the accumulation of advanced glycation end products during a hyperglycemic pregnancy may play a role in PE, as suggested by the report of high skin autofluorescence (SAF) in women after PE (3).

In 97 pregnant women with GDM who consented to participate, we collected serum creatinine at 25 ± 7 weeks of amenorrhea and measured the forearm skin autofluorescence using an AGE Reader (Diagnoptics, Groningen, the Netherlands). Seven women had subsequent PE, and they delivered smaller babies (mean ± SD birth weight 2,666 ± 252 vs. 3,180 ± 525 g; P < 0.05) 2 weeks earlier than the others (P < 0.001). The ages, preconceptional BMI, and HbA1c did not significantly differ between groups; neither did their arterial pressure (systolic 125 ± 10 vs. 114 ± 14 mmHg; diastolic 77 ± 4 vs. 72 ± 9 mmHg; both NS) at 25 ± 7 weeks. However, the serum creatinine was higher for women with later PE (54 ± 6 vs. 46 ± 8 μmol/L; P = 0.012). The SAF did not differ between women with later PE (1.81 ± 0.42 arbitrary units) and without PE (1.84 ± 0.34 arbitrary units).

These normal SAF denied a predictive value for later PE in GDM. Higher SAF values, measured at the leg, as reported after pregnancy, probably resulted from, rather than predisposed to, PE (3): SAF is known to quickly rise during an acute kidney injury (4). This does not exclude a role for advanced glycation end products in specific tissues in the pathophysiology of PE (5).

The higher serum creatinine in GDM with later PE seems in line with the hypothesis of subtle renal abnormalities predisposing to PE in GDM, as proposed by Kelly et al. (1) in T1DM, but it contrasts with the hyperfiltration that they reported. The estimation of GFR should be done cautiously in pregnant women, but our results suggest that serum creatinine may be a parameter of clinical interest in pregnant women with diabetes prone to PE.

Article Information

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

  • © 2018 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Kelly CB,
    2. Hookham MB,
    3. Yu JY, et al
    . Subclinical first trimester renal abnormalities are associated with preeclampsia in normoalbuminuric women with type 1 diabetes. Diabetes Care 2018;41:120–127
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Alper AB,
    2. Yi Y,
    3. Rahman M, et al
    . Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. Am J Perinatol 2011;28:425–430
    OpenUrlCrossRefPubMed
  3. ↵
    1. Coffeng SM,
    2. Blaauw J,
    3. Souwer ET, et al
    . Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly preeclamptic women. Hypertens Pregnancy 2011;30:231–242
    OpenUrlPubMed
  4. ↵
    1. Lavielle A,
    2. Rubin S,
    3. Boyer A, et al
    . Skin autofluorescence in acute kidney injury. Crit Care 2017;21:24
    OpenUrl
  5. ↵
    1. Chen W,
    2. Zhang Y,
    3. Yue C, et al
    . Accumulation of advanced glycation end-products involved in inflammation and contributing to severe preeclampsia, in maternal blood, umbilical cord and placental tissues. Gynecol Obstet Invest 2017;82:388–397
    OpenUrl
View Abstract
PreviousNext
Back to top
Diabetes Care: 41 (6)

In this Issue

June 2018, 41(6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120–127
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120–127
Ninon Foussard, Audrey Cougnard-Gregoire, Kalina Rajaobelina, Cécile Delcourt, Catherine Helmer, Thierry Lamireau, Laurence Blanco, Laure Alexandre, Kamel Mohammedi, Vincent Rigalleau
Diabetes Care Jun 2018, 41 (6) e101; DOI: 10.2337/dc18-0069

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120–127
Ninon Foussard, Audrey Cougnard-Gregoire, Kalina Rajaobelina, Cécile Delcourt, Catherine Helmer, Thierry Lamireau, Laurence Blanco, Laure Alexandre, Kamel Mohammedi, Vincent Rigalleau
Diabetes Care Jun 2018, 41 (6) e101; DOI: 10.2337/dc18-0069
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593–1616
  • Response to Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593–1616
  • Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919
Show more e-Letters: Comments and Responses

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.